R
Ricardo Mondragón
Researcher at National Autonomous University of Mexico
Publications - 3
Citations - 83
Ricardo Mondragón is an academic researcher from National Autonomous University of Mexico. The author has contributed to research in topics: Fluprazine. The author has an hindex of 2, co-authored 3 publications receiving 76 citations. Previous affiliations of Ricardo Mondragón include Instituto Politécnico Nacional.
Papers
More filters
Journal ArticleDOI
Social structure features in three inbred strains of mice, C57Bl/6J, Balb/cj, and NIH: a comparative study.
TL;DR: Differences among strains were that agonistic behavior among subordinates was higher in the Balb/cj and NIH groups than in the C57Bl/6j mice, and dominants showed higher rates of Wheel Running Activity than subordinates.
Journal ArticleDOI
Antiprotozoan lead discovery by aligning dry and wet screening: Prediction, synthesis, and biological assay of novel quinoxalinones
Miriam A. Martins Alho,Yovani Marrero-Ponce,Stephen J. Barigye,Alfredo Meneses-Marcel,Yanetsy Machado Tugores,Alina Montero-Torres,Alicia Gómez-Barrio,Juan José Nogal,Rory N. García-Sánchez,Rory N. García-Sánchez,Maria Celeste Vega,Miriam Rolón,A.R. Martínez-Fernández,José Antonio Escario,Facundo Pérez-Giménez,Ramón García-Domenech,Norma Rivera,Norma Rivera,Ricardo Mondragón,Ricardo Mondragón,Mónica Mondragón,Mónica Mondragón,Froylán Ibarra-Velarde,Atteneri López-Arencibia,Carmen M. Martín-Navarro,Jacob Lorenzo-Morales,Maria Gabriela Cabrera-Serra,José E. Piñero,Jan Tytgat,Roberto Chicharro,Vicente J. Arán +30 more
TL;DR: The described technical framework seems to be a promising QSAR-classifier tool for the molecular discovery and development of novel classes of broad-antiprotozoan-spectrum drugs, which may meet the dual challenges posed by drug-resistant parasites and the rapid progression of protozoan illnesses.
Journal ArticleDOI
Behavioral Effects of Fluprazine in Lactating Hamsters and in Their Progeny
TL;DR: The spontaneous behavior of dams and pups was observed during lactation period, following daily i.p. administration of fluprazine (8 mg/kg/day) to females after parturition.